Manske Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.99M Buy
15,455
+2,746
+22% +$321K 0.49% 41
2026
Q1
$1.53M Buy
12,709
+836
+7% +$96.5K 0.43% 48
2025
Q4
$1.25M Buy
11,873
+1,461
+14% +$137K 0.37% 57
2025
Q3
$874K Buy
10,412
+767
+8% +$63.2K 0.27% 73
2025
Q2
$763K Buy
9,645
+1,433
+17% +$114K 0.25% 75
2025
Q1
$737K Buy
8,212
+193
+2% +$18K 0.28% 73
2024
Q4
$798K Buy
+8,019
New +$827K 0.32% 61

Other funds holding MRK

Manske Wealth Management's MRK Position: Q2 2026 in Review

Manske Wealth Management increased its Merck (MRK) stake by 22% in Q2 2026, buying an estimated $321K and bringing the position to 15,455 shares worth $1.99M. The position accounts for 0.49% of the portfolio, ranked #41.

Manske Wealth Management first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 3,829 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Manske Wealth Management held 15,455 shares of Merck worth $1.99M as of Q2 2026.
  • Manske Wealth Management bought 2,746 Merck shares in Q2 2026, an estimated $321K.
  • Merck made up 0.49% of Manske Wealth Management's portfolio in Q2 2026, its #41 holding.
  • Manske Wealth Management first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 3,829 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Manske Wealth Management's 13F filing for Q2 2026, filed 3 Aug 2026.